Innocan Pharma Corp C.INNO

Private Placement of Units at a 9% Prime Above Share Price

[Betteryear2]

HERZLIYA, Israel, and CALGARY, Alberta, July 25, 2023 /CNW/ -- Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTC: INNPF) (the "Company" or "Innocan") is pleased to announce that it intends to complete a non-brokered private placement of up to 17,220,000 units of the Company (the "Units") at a price of C$0.23 per Unit for gross proceeds up to C$3,960,600 (the "Offering"). The Offering is expected to close on or around July 20, 2023.

Innocan Pharma Announces Private Placement of Units at a 9% Prime Above Share Price (newswire.ca)

[Betteryear2]

Note: There appears to be an error in release. It states: The Offering is expected to close on or around July 20, 2023. The reader should also be aware that it has not yet been posted in Sedar but the release is posted on company's website. The Company website is www.innocanpharma.com.